Protagonist Therapeutics to Present at the JMP Securities Hematology and Oncology Summit
- Friday, December 3, 2021, 7:00
- Finance
- Add a comment
NEWARK, Calif., Dec. 3, 2021 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present at the upcoming JMP Securities Hematology and Oncology Summit taking…